JPH048421B2 - - Google Patents

Info

Publication number
JPH048421B2
JPH048421B2 JP57022154A JP2215482A JPH048421B2 JP H048421 B2 JPH048421 B2 JP H048421B2 JP 57022154 A JP57022154 A JP 57022154A JP 2215482 A JP2215482 A JP 2215482A JP H048421 B2 JPH048421 B2 JP H048421B2
Authority
JP
Japan
Prior art keywords
chain
straight
carbon atoms
lower alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57022154A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57150668A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS57150668A publication Critical patent/JPS57150668A/ja
Publication of JPH048421B2 publication Critical patent/JPH048421B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
JP57022154A 1981-02-18 1982-02-16 Novel 4-aroylimidazole-2-ones Granted JPS57150668A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23545381A 1981-02-18 1981-02-18

Publications (2)

Publication Number Publication Date
JPS57150668A JPS57150668A (en) 1982-09-17
JPH048421B2 true JPH048421B2 (en:Method) 1992-02-17

Family

ID=22885573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57022154A Granted JPS57150668A (en) 1981-02-18 1982-02-16 Novel 4-aroylimidazole-2-ones

Country Status (18)

Country Link
EP (1) EP0058435B1 (en:Method)
JP (1) JPS57150668A (en:Method)
KR (1) KR860001338B1 (en:Method)
AT (1) ATE24496T1 (en:Method)
AU (1) AU558789B2 (en:Method)
CA (1) CA1173047A (en:Method)
DE (1) DE3274855D1 (en:Method)
DK (1) DK161250C (en:Method)
ES (1) ES509636A0 (en:Method)
GB (1) GB2093031B (en:Method)
GR (1) GR76025B (en:Method)
HK (1) HK61586A (en:Method)
IE (1) IE52422B1 (en:Method)
IL (1) IL65010A0 (en:Method)
MY (1) MY8600710A (en:Method)
NZ (1) NZ199733A (en:Method)
PH (1) PH18106A (en:Method)
ZA (1) ZA82969B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4410540A (en) * 1981-11-04 1983-10-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic 4-aroylimidazolidin-2-ones
ZA826501B (en) * 1982-09-06 1984-04-25 Du Pont Anti-hypertensive imidazole derivative
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
WO2005092332A1 (en) * 2004-03-22 2005-10-06 Myogen, Inc. (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
US20060030611A1 (en) * 2004-03-22 2006-02-09 Myogen, Inc. Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
EP4480946A1 (en) * 2017-03-27 2024-12-25 Hydro-Québec Salts for use in electrolyte compositions or as electrode additives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
DE3274855D1 (de) 1987-02-05
CA1173047A (en) 1984-08-21
IE820333L (en) 1982-08-18
GB2093031A (en) 1982-08-25
MY8600710A (en) 1986-12-31
KR860001338B1 (ko) 1986-09-15
AU8048682A (en) 1982-08-26
EP0058435B1 (en) 1986-12-30
ES8307002A1 (es) 1983-07-01
EP0058435A3 (en) 1984-03-21
IL65010A0 (en) 1982-04-30
DK161250B (da) 1991-06-17
GB2093031B (en) 1984-10-24
EP0058435A2 (en) 1982-08-25
ES509636A0 (es) 1983-07-01
KR830009045A (ko) 1983-12-17
ATE24496T1 (de) 1987-01-15
DK161250C (da) 1991-12-09
PH18106A (en) 1985-03-21
ZA82969B (en) 1983-09-28
IE52422B1 (en) 1987-10-28
GR76025B (en:Method) 1984-08-03
DK67582A (da) 1982-08-19
AU558789B2 (en) 1987-02-12
NZ199733A (en) 1985-05-31
JPS57150668A (en) 1982-09-17
HK61586A (en) 1986-08-29

Similar Documents

Publication Publication Date Title
US4816479A (en) Xanthone derivatives and process for producing the same
FR2459233A1 (fr) Nouvelles aroyl-4 imidazolones-2 utiles comme medicaments, leur procede de preparation et compositions therapeutiques les contenant
NZ258896A (en) Heterocyclic substituted benzoxepine and benzocycloheptene derivatives; pharmaceutical compositions thereof
JPH048421B2 (en:Method)
US3804904A (en) Substituted phenyl sulphoxides and sulphones and the use thereof as vasodilators
KR900006118B1 (ko) 4-퀴놀론 유도체의 제법
HUT63610A (en) Process for producing immune modifying n-phenyl-2-cyano-3-hydroxycrotonic acid derivatives and pharmaceutical compositions comprising such compounds
JP2001526275A (ja) 中枢神経系障害の治療のためのトリアジン化合物
CH631179A5 (fr) Tetrahydro-4,5,6,7 thieno (2,3-c) et (3,2-c) pyridines et leur procede de preparation.
JP4657917B2 (ja) 高コンダクタンス型カルシウム感受性ｋチャネル開口薬
KR880002708B1 (ko) 4-아로일이미다졸리딘-2-온의 제조방법
KR890005203B1 (ko) 티아졸론 유도체 및 이의 제조방법
KR900003879B1 (ko) 5-아릴-2,4-디알킬-3h-1,2,4-트리아졸-3-티온 및 이의 제조방법
HU192634B (en) Pharmaceutical compositions containing process for preparing 4-aroyl-imidazol-2-one derivatives
JPH11512101A (ja) 新規の抗痙攣作用を有する４位に二置換アミン基を有する１−アリール（アラルキル）−イミダゾリン−２−オンおよびその製法
KR890001151B1 (ko) 이미다졸 카복실산 유도체의 제조방법
FR2781221A1 (fr) Piperazinones substituees en alpha
DE69113773T2 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
HU206880B (en) Process for producing oxazolone derivatives and pharmaceutical compositions containing them
JPH0414111B2 (en:Method)
FI90076B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-pyridyl- och 5-tienyl-2,4-dialkyl-3h-1,2,4-triazol-3-tion-derivat
EP0197533B1 (en) Dioxolobenzisoxazole derivatives and process for preparing the same
NO156527B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aroylimidazol-2-oner.
US4775689A (en) 5-(naphthyl)-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
US4977185A (en) Antiretroviral aryloxy substituted furan ketones